|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2348 USD | -16.35% |
|
-19.78% | -52.85% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -6.08 | -7.95 | -20.36 | -15.85 | -17.26 | |||||
Return on Total Capital | -9.07 | -10.83 | -26.83 | -22.48 | -27.66 | |||||
Return On Equity % | -7.29K | -62.81 | -48.99 | -53.43 | -89.13 | |||||
Return on Common Equity | -14.28K | -292.9 | -68.46 | -73.88 | -89.13 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.81 | 11.83 | 8.15 | 7.92 | 12.1 | |||||
SG&A Margin | 22.07 | 26.3 | 47.9 | 32.67 | 34.54 | |||||
EBITDA Margin % | -7.43 | -14.64 | -39.79 | -25.78 | -23.26 | |||||
EBITA Margin % | -8 | -14.78 | -40.45 | -26.57 | -23.92 | |||||
EBIT Margin % | -8.06 | -14.84 | -40.9 | -28.02 | -25.34 | |||||
Income From Continuing Operations Margin % | -14.16 | -27.47 | -34.74 | -29.73 | -29.33 | |||||
Net Income Margin % | -14.16 | -27.47 | -34.74 | -29.73 | -29.33 | |||||
Net Avail. For Common Margin % | -27.73 | -127.01 | -48.31 | -41.12 | -29.33 | |||||
Normalized Net Income Margin | -9.6 | -17.46 | -25.64 | -18.25 | -16.97 | |||||
Levered Free Cash Flow Margin | 4.55 | -8.34 | -31.62 | -1.19 | -17.92 | |||||
Unlevered Free Cash Flow Margin | 7.18 | -6.63 | -30.6 | -0.03 | -16.52 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.21 | 0.86 | 0.8 | 0.9 | 1.09 | |||||
Fixed Assets Turnover | 30.92 | 17.17 | 7.34 | 4.97 | 6.05 | |||||
Receivables Turnover (Average Receivables) | 2.24 | 2.04 | 2.46 | 3.27 | 3.94 | |||||
Inventory Turnover (Average Inventory) | 7.27 | 6.73 | 11.9 | 10.96 | 11.32 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.37 | 2.58 | 1.51 | 0.99 | 1 | |||||
Quick Ratio | 1 | 2.15 | 1.03 | 0.63 | 0.61 | |||||
Operating Cash Flow to Current Liabilities | -0.24 | -0.68 | -0.64 | -0.3 | -0.22 | |||||
Days Sales Outstanding (Average Receivables) | 163.22 | 178.54 | 148.56 | 111.76 | 92.57 | |||||
Days Outstanding Inventory (Average Inventory) | 50.17 | 54.2 | 30.68 | 33.39 | 32.23 | |||||
Average Days Payable Outstanding | 92.64 | 98.07 | 80.89 | 90.5 | 90.18 | |||||
Cash Conversion Cycle (Average Days) | 120.76 | 134.66 | 98.35 | 54.64 | 34.62 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 654.83 | 34.24 | 34.47 | 48.18 | 108.39 | |||||
Total Debt / Total Capital | 86.75 | 25.51 | 25.63 | 32.52 | 52.01 | |||||
LT Debt/Equity | 345.28 | 13.3 | 10.78 | 8.41 | 33.79 | |||||
Long-Term Debt / Total Capital | 45.74 | 9.91 | 8.02 | 5.67 | 16.21 | |||||
Total Liabilities / Total Assets | 91.14 | 41.71 | 45.4 | 54.83 | 71.86 | |||||
EBIT / Interest Expense | -1.27 | -1.88 | -25.2 | -15.07 | -6.31 | |||||
EBITDA / Interest Expense | -1.09 | -1.81 | -24.09 | -13.57 | -5.69 | |||||
(EBITDA - Capex) / Interest Expense | -1.26 | -1.82 | -27.53 | -13.98 | -5.71 | |||||
Total Debt / EBITDA | -7.32 | -1.9 | -0.6 | -0.86 | -1.34 | |||||
Net Debt / EBITDA | -7.24 | 1 | -0.41 | -0.84 | -1.29 | |||||
Total Debt / (EBITDA - Capex) | -6.37 | -1.88 | -0.52 | -0.84 | -1.33 | |||||
Net Debt / (EBITDA - Capex) | -6.31 | 0.99 | -0.36 | -0.81 | -1.28 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.5 | -10.48 | 6.02 | 1.97 | 19.93 | |||||
Gross Profit, 1 Yr. Growth % | 3.35 | -28.49 | -26.98 | -0.88 | 83.14 | |||||
EBITDA, 1 Yr. Growth % | -239.91 | 76.29 | 188.17 | -33.93 | 8.17 | |||||
EBITA, 1 Yr. Growth % | -263.8 | 65.34 | 190.17 | -33.03 | 8 | |||||
EBIT, 1 Yr. Growth % | -267.02 | 64.87 | 192.09 | -30.13 | 8.44 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -1.07K | 73.71 | 34.07 | -12.73 | 18.3 | |||||
Net Income, 1 Yr. Growth % | -1.07K | 73.71 | 34.07 | -12.73 | 18.3 | |||||
Normalized Net Income, 1 Yr. Growth % | -3.07K | 62.85 | 55.74 | -27.42 | 11.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -1.68K | 39.7 | -93.5 | -45.69 | -45.98 | |||||
Accounts Receivable, 1 Yr. Growth % | 14.58 | -14.08 | -16.6 | -31.79 | 45.63 | |||||
Inventory, 1 Yr. Growth % | -5.19 | 5.64 | 38.74 | -9.06 | 32.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.03 | -0.13 | 296.46 | -9.51 | 7.5 | |||||
Total Assets, 1 Yr. Growth % | 12.74 | 37.65 | -2.97 | -17.73 | 20.56 | |||||
Tangible Book Value, 1 Yr. Growth % | -188.5 | 890.76 | -26.49 | -40.58 | -35.3 | |||||
Common Equity, 1 Yr. Growth % | -205.25 | 797.01 | -8.25 | -31.93 | -24.9 | |||||
Cash From Operations, 1 Yr. Growth % | -38.29 | 109.53 | 5.15 | -50.65 | 9.47 | |||||
Capital Expenditures, 1 Yr. Growth % | 393.78 | -87.24 | 3.91K | -85.96 | -86.68 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -118.46 | -216.37 | 273.45 | -96.15 | 1.7K | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -133.27 | -165.62 | 346.23 | -99.9 | 63.93K | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 19.06 | -4.67 | -2.58 | 3.97 | 10.58 | |||||
Gross Profit, 2 Yr. CAGR % | 50.82 | -14.03 | -27.74 | -14.93 | 34.73 | |||||
EBITDA, 2 Yr. CAGR % | 1.29K | 57.05 | 125.39 | 37.98 | -15.46 | |||||
EBITA, 2 Yr. CAGR % | 349.51 | 64.57 | 119.04 | 39.4 | -14.96 | |||||
EBIT, 2 Yr. CAGR % | 320.97 | 65.94 | 119.45 | 42.86 | -12.96 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 55.35 | 310.49 | 52.61 | 8.17 | 1.61 | |||||
Net Income, 2 Yr. CAGR % | 55.35 | 310.49 | 52.61 | 8.17 | 1.61 | |||||
Normalized Net Income, 2 Yr. CAGR % | 113.4 | 595.44 | 59.26 | 6.32 | -10.03 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 94.94 | 370.2 | -69.88 | -81.22 | -45.83 | |||||
Accounts Receivable, 2 Yr. CAGR % | 91.17 | -1.46 | -13.64 | -24.57 | -0.33 | |||||
Inventory, 2 Yr. CAGR % | 4.03 | 0.08 | -13.57 | 12.33 | 9.84 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.12 | 29.13 | 98.99 | 88.4 | -1.37 | |||||
Total Assets, 2 Yr. CAGR % | 43.87 | 24.57 | 15.57 | -10.66 | -0.41 | |||||
Tangible Book Value, 2 Yr. CAGR % | -23.98 | 196.39 | 169.88 | -34.05 | -38 | |||||
Common Equity, 2 Yr. CAGR % | -17.67 | 207.26 | 186.88 | -20.97 | -28.5 | |||||
Cash From Operations, 2 Yr. CAGR % | 21.74 | 13.71 | 48.43 | -27.96 | -26.5 | |||||
Capital Expenditures, 2 Yr. CAGR % | -7.04 | -20.61 | 126.33 | 137.36 | -86.33 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -29.87 | -44.95 | 116.32 | -62.09 | -16.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -4.59 | -47.55 | 79.18 | -93.22 | -18.75 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.89 | 8.26 | -1.24 | -1.09 | 9.04 | |||||
Gross Profit, 3 Yr. CAGR % | 51.23 | 17.6 | -18.59 | -19.71 | 9.85 | |||||
EBITDA, 3 Yr. CAGR % | 52.26 | 597.48 | 92.27 | 49.73 | 27.23 | |||||
EBITA, 3 Yr. CAGR % | 54.55 | 222.07 | 98.82 | 47.56 | 28.03 | |||||
EBIT, 3 Yr. CAGR % | 54.53 | 208 | 100.36 | 49.84 | 30.32 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -4.22 | 61.24 | 182.69 | 26.67 | 11.45 | |||||
Net Income, 3 Yr. CAGR % | -4.22 | 61.24 | 182.69 | 26.67 | 11.45 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.2 | 95.01 | 322.32 | 22.56 | 8.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.74 | 74.42 | 12.82 | -63.34 | -73.29 | |||||
Accounts Receivable, 3 Yr. CAGR % | 78.11 | 45.77 | -5.54 | -20.17 | -6.08 | |||||
Inventory, 3 Yr. CAGR % | -6.34 | 4.56 | -10.86 | -12.09 | 18.73 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.67 | 19.09 | 87.68 | 52.48 | 56.26 | |||||
Total Assets, 3 Yr. CAGR % | 33.67 | 41.77 | 14.62 | 3.19 | -1.27 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.45 | 79.02 | 86.22 | 62.72 | -34.47 | |||||
Common Equity, 3 Yr. CAGR % | 9.7 | 82.52 | 105.37 | 77.6 | -22.3 | |||||
Cash From Operations, 3 Yr. CAGR % | 65.87 | 45.89 | 10.78 | 2.83 | -17.18 | |||||
Capital Expenditures, 3 Yr. CAGR % | 4.92 | -52.04 | 193.54 | -10.41 | -9.13 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.99 | -6.88 | 6.82 | -43.53 | 37.31 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.99 | -9.03 | 10.42 | -85.1 | 43.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 52.78 | 10.9 | 7.56 | 6.53 | 3.33 | |||||
Gross Profit, 5 Yr. CAGR % | 69.18 | 24.95 | 12.55 | 3.32 | -0.41 | |||||
EBITDA, 5 Yr. CAGR % | 84.98 | 20.54 | 78.13 | 264.8 | 38.41 | |||||
EBITA, 5 Yr. CAGR % | 85.93 | 20.62 | 77.68 | 130.4 | 41.56 | |||||
EBIT, 5 Yr. CAGR % | 86.21 | 20.66 | 77.81 | 126.51 | 43.54 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 67.66 | 17.37 | 15.4 | 37.45 | 87.74 | |||||
Net Income, 5 Yr. CAGR % | 67.66 | 17.37 | 15.4 | 37.45 | 87.74 | |||||
Normalized Net Income, 5 Yr. CAGR % | 70.44 | 26.99 | 21.32 | 52.99 | 127.52 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 80.2 | 22.04 | -33.86 | -28.47 | -15.87 | |||||
Accounts Receivable, 5 Yr. CAGR % | 109.73 | 78.51 | 32.97 | 12.9 | -3.49 | |||||
Inventory, 5 Yr. CAGR % | 69.06 | 16.96 | -9.3 | -5.97 | -3.09 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 104.4 | 91.23 | 52.13 | 43.07 | 44.78 | |||||
Total Assets, 5 Yr. CAGR % | 73.78 | 44.83 | 26.11 | 17.86 | 8.35 | |||||
Tangible Book Value, 5 Yr. CAGR % | 17.26 | 65.9 | 50.99 | 20.06 | 19.84 | |||||
Common Equity, 5 Yr. CAGR % | 20.1 | 66.96 | 61.14 | 30.58 | 34.66 | |||||
Cash From Operations, 5 Yr. CAGR % | 27.26 | 11.16 | 58.66 | 10.01 | -5.99 | |||||
Capital Expenditures, 5 Yr. CAGR % | 114.46 | 6.04 | 42.7 | -9.08 | -13.91 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.44 | -8.59 | 55.27 | -34.03 | -3.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 22.84 | -11.27 | 37.72 | -67.2 | -2.33 |
- Stock Market
- Stocks
- COSM Stock
- Financials Cosmos Health Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















